Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Molecular and Cellular Endocrinology
|
June 16, 2000
A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus
J Berger, H V Patel, J Woods, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2001
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
T Claudel, M D Leibowitz, C Fiévet, et al.
Molecular Pharmacology
|
February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity
P J Davies, S A Berry, G L Shipley, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2003
Design and synthesis of fluorinated RXR modulators
D L Gernert, R Ajamie, R A Ardecky, et al.
The Journal of Biological Chemistry
|
April 19, 1996
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice
B Zhang, M P Graziano, T W Doebber, et al.
FEBS Letters
|
May 20, 2000
Activation of PPARdelta alters lipid metabolism in db/db mice
M D Leibowitz, C Fiévet, N Hennuyer, et al.
The Journal of Biological Chemistry
|
February 26, 1999
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects
J Berger, M D Leibowitz, T W Doebber, et al.
Journal of Medicinal Chemistry
|
June 13, 2003
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes
P Y Michellys, R J Ardecky, J H Chen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Molecular and Cellular Endocrinology
|
June 16, 2000
A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus
J Berger, H V Patel, J Woods, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 28, 2001
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
T Claudel, M D Leibowitz, C Fiévet, et al.
Molecular Pharmacology
|
February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity
P J Davies, S A Berry, G L Shipley, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2003
Design and synthesis of fluorinated RXR modulators
D L Gernert, R Ajamie, R A Ardecky, et al.
The Journal of Biological Chemistry
|
April 19, 1996
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice
B Zhang, M P Graziano, T W Doebber, et al.
FEBS Letters
|
May 20, 2000
Activation of PPARdelta alters lipid metabolism in db/db mice
M D Leibowitz, C Fiévet, N Hennuyer, et al.
The Journal of Biological Chemistry
|
February 26, 1999
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects
J Berger, M D Leibowitz, T W Doebber, et al.
Journal of Medicinal Chemistry
|
June 13, 2003
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes
P Y Michellys, R J Ardecky, J H Chen, et al.
Page
of 3